Actively Recruiting

Phase 3
Age: 18Years +
All Genders
NCT06635798

A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR2001 Injection

Led by Genrix (Shanghai) Biopharmaceutical Co., Ltd. · Updated on 2024-10-10

582

Participants Needed

20

Research Sites

26 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to compare the efficacy and safety of GR2001 injection with Human Tetanus Immunoglobulin(HTIG) in tetanus prophylaxis. Patients will receive either GR2001 injection or HTIG on study D0.

CONDITIONS

Official Title

A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR2001 Injection

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Chinese male or female adults aged 18 years or older
  • Participants with suspected tetanus exposure due to dirty or contaminated wounds
  • Participants who provide signed written informed consent
Not Eligible

You will not qualify if you...

  • Known allergy to the investigational product or severe allergic conditions
  • Suspected or diagnosed tetanus infection
  • Diagnosed Immunoglobulin A (IgA) deficiency with anti-IgA antibodies
  • History of three or more doses of tetanus toxoid or tetanus-containing vaccine
  • Females who are pregnant or have a positive pregnancy test

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 20 locations

1

The Second Affiliated Hospital of Anhui Medical University

Hefei, Anhui, China, 230601

Actively Recruiting

2

Peking University First Hospital

Beijing, Beijing Municipality, China, 100034

Actively Recruiting

3

Peking University People Hospital

Beijing, Beijing Municipality, China, 100044

Actively Recruiting

4

Beijing Tiantan Hospital

Beijing, Beijing Municipality, China, 100050

Actively Recruiting

5

The First Affiliated Hospital of Guangzhou Medical University

Guangzhou, Guangdong, China, 510120

Actively Recruiting

6

The Third Affiliated Hospital of Guangzhou Medical University

Guangzhou, Guangdong, China, 510150

Actively Recruiting

7

Zhujiang Hospital Affiliated to Southern Medical University

Guangzhou, Guangdong, China, 510280

Actively Recruiting

8

Shenzhen Second People's Hospital

Shenzhen, Guangdong, China, 518037

Actively Recruiting

9

Liuzhou People's Hospital

Liuzhou, Guangxi, China, 545006

Actively Recruiting

10

Liuzhou Workers's Hospital

Liuzhou, Guangxi, China, 545025

Actively Recruiting

11

The Affiliated Hospital of Zunyi Medical University

Zunyi, Guizhou, China, 563000

Actively Recruiting

12

The Central Hospital of Wuhan

Wuhan, Hubei, China, 430014

Actively Recruiting

13

Tongji Hospital, Tongji Medical College of HUST

Wuhan, Hubei, China, 430030

Actively Recruiting

14

Nanhua Hospital Affiliated to University of south China

Hengyang, Hunan, China, 421010

Actively Recruiting

15

The Affiliated Hospital of Yangzhou University

Yangzhou, Jiangsu, China, 225009

Actively Recruiting

16

The Second Affiliated Hospital of Nanchang University

Nanchang, Jiangxi, China, 330006

Actively Recruiting

17

Huashan Hospital, Fudan University

Shanghai, Shanghai Municipality, China, 200040

Actively Recruiting

18

Linfen Central Hospital

Linfen, Shanxi, China, 041000

Actively Recruiting

19

Yuncheng Central Hospital

Yuncheng, Shanxi, China, 044000

Actively Recruiting

20

Zhejiang Provincial People's Hospital

Hangzhou, Zhejiang, China, 310014

Actively Recruiting

Loading map...

Research Team

C

Chuanlin Wang, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR2001 Injection | DecenTrialz